OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 78 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,380 | +36.8% | 2,217 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $20,020 | +150.2% | 2,217 | +14.8% | 0.00% | – |
| Q1 2022 | $8,000 | -55.6% | 1,931 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $18,000 | -66.0% | 1,931 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $53,000 | +89.3% | 1,931 | +95.6% | 0.00% | +100.0% |
| Q2 2021 | $28,000 | -15.2% | 987 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $33,000 | – | 987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |